Hypertension, Pregnancy Induced
11
4
6
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
36%
4 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (11)
Enhancing Care & Outcomes for Patients During the First Postpartum Year
Randomized Controlled Trial of Two Mobile Health Strategies to Manage Postpartum Hypertension
Treatment With Aspirin After Preeclampsia: TAP Trial
Optimal Blood Pressure Treatment Thresholds Postpartum
Better Understanding Patient Perspectives of an Educational Tool for Postpartum Hypertensive Patients
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
Treatment Preventive for Pre-eclampsia by Acetylsalicylic Acid in Women Who Underwent Frozen Embryo Transfer
Blood Pressure Variability Effect on Right Ventricular Strain in Women With Hypertensive Disorders With Pregnancy
Community Level Interventions for Pre-eclampsia
Randomized Controlled Trial of Labetalol Versus Hydralazine for Severe Hypertension in Obstetric Patients.
Hydralazine Versus Labetalol for the Management of Hypertensive Disorders of Pregnancy